Concepedia

Olivier Leupin

OL

15

Publications

1.5K

Citations

15

H-Index

2000

Active since

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

University of Geneva

Lawrence Livermore National Laboratory

ZHAW Zurich University of Applied Sciences

Olivier Leupin is an author at Novartis (Switzerland) specializing in medicine, cell biology, and immunology.

Top concepts

Publications per year

2000–2018

15

Publications

15

Bone Overgrowth-associated Mutations in the LRP4 Gene Impair Sclerostin Facilitator Function

Olivier Leupin, Elke Piters, Christine Halleux et al. · Journal of Biological Chemistry · 2011 · 297 citations · Full text

Control of the <i>SOST</i> Bone Enhancer by PTH Using MEF2 Transcription Factors

Olivier Leupin, Ina Krämer, Nicole M. Collette et al. · Journal of Bone and Mineral Research · 2007 · 247 citations · Full text

Hepatitis B Virus X Protein Stimulates Viral Genome Replication via a DDB1-Dependent Pathway Distinct from That Leading to Cell Death

Olivier Leupin, Séverine Bontron, Céline Schaeffer et al. · Journal of Virology · 2005 · 163 citations · Full text

Exclusion of CD45 from the T-cell receptor signaling area in antigen-stimulated T lymphocytes

Olivier Leupin, Rossana Zaru, Thierry Laroche et al. · Current Biology · 2000 · 146 citations · Full text

, , +11

Disruption of Lrp4 function by genetic deletion or pharmacological blockade increases bone mass and serum sclerostin levels

Ming-Kang Chang, Ina Krämer, Thomas Huber et al. · Proceedings of the National Academy of Sciences · 2014 · 119 citations · Full text

Rows per page

1–5 of 15